GHIT Fund Announces Investments In Malaria, TB Diagnostics, NTD Treatment
Global Health Innovative Technology Fund: GHIT Fund Announces New Investments, Including Innovative Malaria Vaccine Targeting Two Deadliest Strains of the Disease
The Global Health Innovative Technology Fund announced investments in two innovative malaria eradication tools, a new rapid diagnostic test that can identify active tuberculosis in HIV-positive patients, and efforts to develop new treatments for soil-transmitted helminth (STH) infections and cutaneous leishmaniasis (CL) (3/31).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.